Eyeworld

March 2011 site through an applicator. The bandage is CE-mark approved but not yet commercially available in the United States. The OcuSeal Liq- uid Ocular Bandage (Beaver-Visitec International, Waltham, Mass.) is made of a synthetic dendritic hydro- gel that is applied as a liquid. The hydrogel is activated after mixing powder polyethylene glycol (PEG) and liquid polyethylene amine (PEI) and crosslinks 30 seconds after ap- plication. Dr. Kim said adhesives offer a vi- able alternative to sutures for sealing cataract incisions. "I think as we move toward more elective proce- dures, elective IOLs, this may be- come part of that arena, too," he said. Editors' note: Dr. Braga-Mele has finan- cial interests with AMO and Alcon. Dr. Solomon has a financial interest in LensAR (Winter Park, Fla.). Dr. Kim has a financial interest in the OcuSeal Bandage. Posterior segment challenges Keith A. Warren, M.D., founder, Warren Retina Associates, and clini- cal professor of ophthalmology, Uni- versity of Kansas, Lawrence, and William F. Mieler, M.D., professor and vice chairman, department of ophthalmology and visual sciences, University of Illinois at Chicago, gave a talk focusing on various pos- terior segment challenges for the an- terior segment surgeon. During the vitectomy for the anterior segment surgeon portion of the discussion, Dr. Warren said indi- cations for vitreous surgery are a capsular rupture during phaco, a vit- reous prolapse, pediatric or trau- matic cataract, and posterior vitreous pressure. He also spoke of the advantages and disadvantages of small-gauge cutters. Advantages include suture- less/self-sealing incisions, reduced recovery time, and reduced surgery time. Disadvantages of small-gauge cutters are a longer vitrectomy time, flimsy instrumentation, and possibly an increased risk of endophthalmi- tis, among others. Dr. Mieler focused on the pre- vention and management of infec- tion in cataract cases. "As we all know, there's roughly a 0.1 to 0.5% risk of infection following routine 2 9 7 5 B r o t h e r B l v d B a r t l e t t T N 3 8 1 3 3 8 8 8 . 9 0 5 . 7 7 7 0 o d y s s e y m e d . c o m © 2010 Odyssey Medical, Inc. All rights reser ved. †Market Scope Dr y Eye Report (June 2003) ‡McCabe, C. (2009). Punctal occlusion reduces dr y eye symptoms and improves vision. Review of Ophthalmolog y, 16(11), 55-58 *Some conditions apply; call for details. C A L L F O R A F R E E I N T R O D U C T O R Y T R I A L D E S I G N E D L I K E N O O T H E R . 92% # 1 ‡ AMONG ALL COMPETITORS † IN THE DRY EYE MARKET % 9 , I l a c i d e y M e s s y d 0 O 1 0 © 2 t p m y s e y e y r d s e c u d e r . d e v r e s e s r t h g i l r l . A c n , I † ) 3 0 0 e 2 n u J t ( r o p e e R y y E r e D p o c t S e k r a M ‡M e m o S * 8 5 - 5 5 , ) 1 1 ( 6 1 , y g o l o m l a h t h p f O w o e i v e R . n o i s i s v e v o r p m i d n s a m o n o i s u l c c l o a t c n u . P 9) 0 0 2 . ( , C e b a C c . s l i a t e d r o l f l a ; c y l p p a s n o i t i d n o c continued from page 118

• Cover